Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berta Mosleh

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 24, 2024
The impact of restricted chests on long-term lung function parameters following lung transplantation in patients with interstitial lung diseaseKeita Nakanishi, Thomas Schweiger, Stefan Schwarz, et al.
Thoracic Cancer|March 11, 2025
Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural MesotheliomaBerta Mosleh, Stefan Schwarz, Anna Cho, et al.
Antioxidants (Basel, Switzerland)|January 28, 2026
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural MesotheliomaMuhammad Hashim, Gerald Timelthaler, Dominik Kirchhofer, et al.
Diagnostics (Basel, Switzerland)|May 4, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural MesotheliomaBerta Mosleh, Yawen Dong, Elisabeth Lang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 22, 2023
Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatinAlexander Ries, Daniela Flehberger, Astrid Slany, et al.
Thoracic Cancer|June 21, 2023
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosisBerta Mosleh, Karin Schelch, Thomas Mohr, et al.
Cancers|April 26, 2025
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural MesotheliomaBerta Mosleh, Katharina Sinn, Anna Cho, et al.
Translational Lung Cancer Research|May 20, 2021
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter studyLuka Brcic, Thomas Klikovits, Zsolt Megyesfalvi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 24, 2024
The impact of restricted chests on long-term lung function parameters following lung transplantation in patients with interstitial lung diseaseKeita Nakanishi, Thomas Schweiger, Stefan Schwarz, et al.
Thoracic Cancer|March 11, 2025
Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural MesotheliomaBerta Mosleh, Stefan Schwarz, Anna Cho, et al.
Antioxidants (Basel, Switzerland)|January 28, 2026
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural MesotheliomaMuhammad Hashim, Gerald Timelthaler, Dominik Kirchhofer, et al.
Diagnostics (Basel, Switzerland)|May 4, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural MesotheliomaBerta Mosleh, Yawen Dong, Elisabeth Lang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 22, 2023
Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatinAlexander Ries, Daniela Flehberger, Astrid Slany, et al.
Thoracic Cancer|June 21, 2023
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosisBerta Mosleh, Karin Schelch, Thomas Mohr, et al.
Cancers|April 26, 2025
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural MesotheliomaBerta Mosleh, Katharina Sinn, Anna Cho, et al.
Translational Lung Cancer Research|May 20, 2021
Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter studyLuka Brcic, Thomas Klikovits, Zsolt Megyesfalvi, et al.
Pageof 2